# First Human Clinical Trial: CBG Reduces Anxiety and Stress Without Intoxication > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbg-clinical-trial-anxiety-stress-relief/ > **Published:** 2026-02-23T12:55:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T12:02:06-04:00 > **Clinical Summary:** Discover how the CBG clinical trial anxiety study shows significant stress relief without intoxication in healthy adults. --- CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDAnxietyHemp Why This Matters If Texas—one of America’s most conservative states and a major hemp producer—signals voter support for legalization, it could dramatically accelerate federal cannabis reform that affects your access to products. Clinical Summary In one of the first double-blind, placebo-controlled [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) of isolated CBG in humans, a 20mg oral dose of hemp-derived cannabigerol produced statistically significant reductions in subjective anxiety and stress, along with improved verbal memory, without intoxication, cognitive slowing, or motor impairment. The study of 34 healthy adults suggests CBG may influence stress and anxiety pathways without producing typical ‘drug effects.’ Researchers emphasize preliminary nature and need for replication. CBG also shows antimicrobial activity against antibiotic-resistant organisms in lab settings. CBGA’s interaction with PPAR receptors suggests metabolic disorder applications. Dr. Caplan’s Take “When marijuana legalization appears on a Texas primary ballot, the political ground has shifted beneath everyone’s feet, this is no longer a blue-state issue, and Congress needs to wake up to that reality.” Clinical Perspective CBG JUST HAD ITS BREAKTHROUGH MOMENT For years, cannabigerol (CBG) has been called ‘the mother of all cannabinoids’—the chemical precursor from which THC, CBD, and other compounds are derived. But clinical evidence in humans has been virtually nonexistent. That just changed. In one of the first double-blind, placebo-controlled trials of isolated CBG in humans, researchers found that a single 20mg oral dose of hemp-derived CBG produced statistically significant reductions in anxiety and stress, improved verbal memory, and caused zero intoxication, cognitive slowing, or motor impairment. The study of 34 healthy adults suggests that CBG operates through stress and anxiety pathways without activating the psychoactive mechanisms associated with THC. This is precisely the kind of evidence the medical community has been demanding before taking [minor cannabinoids](https://cedclinic.com/cbd-vs-thc-vs-cbg-vs-cbn-vs-thcv-differences/) seriously. Beyond mental health, CBG shows promise in other domains. Laboratory studies demonstrate antimicrobial activity against antibiotic-resistant organisms. CBGA—the acidic form—interacts with PPAR receptors involved in lipid metabolism, insulin sensitivity, and inflammatory regulation, suggesting potential applications in metabolic disorders. The researchers are appropriately cautious, emphasizing that these findings are preliminary and require replication with larger, more diverse populations. But the signal is clear: CBG is not a minor cannabinoid. It may be a major therapeutic tool. Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+First+Human+Clinical+Trial%3A+CBG+Reduces+Anxiety+and+Stress+Without+Intoxication+%40drcaplan&url=https%3A%2F%2Frealmofcaring.org%2Fcbg-cbga-research-updates-potential-benefits%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Frealmofcaring.org%2Fcbg-cbga-research-updates-potential-benefits%2F) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+First+Human+Clinical+Trial%3A+CBG+Reduces+Anxiety+and+Stress+Without+Intoxication+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Frealmofcaring.org%2Fcbg-cbga-research-updates-potential-benefits%2F) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Study: Cannabis Beverages Help People Cut Alcohol Consumption Nearly in Half](https://cedclinic.com/cannabis-beverage-users-alcohol-reduction/) 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) 📰 Source: [https://realmofcaring.org/cbg-cbga-research-updates-potential-benefits/](https://realmofcaring.org/cbg-cbga-research-updates-potential-benefits/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis compounds show promise in fighting fatty liver disease, scientists say – AZERTAC](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) Explore emerging research on [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) and their potential benefits for [liver health](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/). [Learn More](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) [Cannabis compounds may improve metabolism and reduce diabetes risk](https://cedclinic.com/cannabis-compounds-may-improve-metabolism-and-reduce-diabetes-risk/) Discover how cannabis compounds might influence metabolic health and diabetes risk reduction. [Read Article](https://cedclinic.com/cannabis-compounds-may-improve-metabolism-and-reduce-diabetes-risk/) [Texas hemp rules set to take effect March 31, Laredo smoke shops brace for impact – KGNS](https://cedclinic.com/texas-hemp-rules-impact-smoke-shops-march-31/) Stay informed about new Texas hemp regulations and their impact on [cannabis access](https://cedclinic.com/medical-cannabis-delivery-services-growth-dmv-jamaica/) and products. [Stay Updated](https://cedclinic.com/texas-hemp-rules-impact-smoke-shops-march-31/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).